Clinical Trial Update: A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

Ongoing Phase 2/Phase 3 trial evaluating a fully automated Lyumjev and pramlintide delivery system for adults with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lyumjev (insulin lispro)
• pramlintide (pramlintide)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: type1diabetes, Diabetes Mellitus, Type 1 | Phase 2, Phase 3 | Status: RECRUITING